Clinical trial Recruiting at 1 site Observational Ages 18 to 39

Observational study on young adult cancer survivors

Official title: COMPRehensive Assessment of Prevalence, Risk Factors and Mechanisms of Impaired Medical and Psychosocial Health Outcomes Among Adolescents and Young Adults With Cancer: the Prospective Observational COMPRAYA Cohort Study

Run by The Netherlands Cancer Institute · NCT04682470 · Data updated 2026-11-12

This study looks at young adults who have survived cancer to see how their long-term health and quality of life are affected.

Quick facts

Study typeObservational
Ages18 Years to 39 Years
SexAll
Enrollment4000 (estimated)
SponsorThe Netherlands Cancer Institute
Academic / other
Drugs / interventionschemotherapy, immunotherapy
Locations1 site (Amsterdam, North Holland)
StatusRecruiting
StartedJune 18, 2021
Main results expectedJune 2025
Study endsJune 2035
Registry record updatedMarch 2, 2022
Trial IDNCT04682470 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are young adults aged 18-39 who have a confirmed diagnosis of cancer.

Probably not a fit

Patients who are mentally incompetent or unable to understand the Dutch language may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on young adults aged 18-39 who have survived cancer, aiming to understand the long-term health-related quality of life issues they face. It highlights the unique challenges this demographic encounters, including delays in diagnosis and the need for specialized follow-up care. By collecting data on their experiences, the study seeks to identify the psychosocial and medical impacts of survivorship. The findings may help improve care strategies for this population.

Why it matters

Potential benefit: If successful, this study could lead to enhanced support and care strategies for young adult cancer survivors, improving their quality of life.

How similar studies have gone: While there is ongoing research into cancer survivorship, this specific focus on young adults is relatively novel and underexplored.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pathological confirmed cancer diagnosis;
* Age 18 - 39 years at time of first cancer diagnosis;
* Able to understand the informed consent form;
* Provide written informed consent.

Exclusion Criteria:

* Mentally incompetent patients based on the opinion of treating physician .
* Inability to understand the Dutch language
* Life expectancy less than 6 months based on the opinion of treating physician .

Where it's running

  • Antoni van Leeuwenhoekziekenhuis
    Amsterdam, North Holland, Netherlands
    Recruiting

Study contacts

  • Principal investigator: Olga Husson, Phd — Netherlands Cancer Institute- Antoni van Leeuwenhoek Hospital (NKI-AvL)
  • Study coordinator: Renske Fles, Phd
  • Email: r.fles@nki.nl
  • Phone: +31 20 512 6993

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.